$1000 Invested In This Stock 5 Years Ago Would Be Worth $3,000 Today
Portfolio Pulse from Benzinga Insights
Apellis Pharmaceuticals (NASDAQ:APLS) has significantly outperformed the market with an annualized return of 23.52% over the past 5 years, turning a $1000 investment into $3,017.45 today. The company's market capitalization stands at $7.02 billion.
March 29, 2024 | 9:00 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Apellis Pharmaceuticals has delivered a remarkable annualized return of 23.52% over the past 5 years, growing a $1000 investment to $3,017.45.
The significant outperformance of Apellis Pharmaceuticals compared to the market, as evidenced by its 23.52% annualized return over 5 years, highlights the company's strong growth trajectory. This performance, coupled with a substantial market capitalization of $7.02 billion, suggests a positive outlook for APLS stock in the short term. Investors may view this historical performance as indicative of the company's potential for continued success.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100